Literature DB >> 22850143

Local IRBs vs. federal agencies: shifting dynamics, systems, and relationships.

Robert L Klitzman1.   

Abstract

How IRBs relate to federal agencies, and the implications of these relationships, have received little, if any, systematic study. I interviewed 46 IRB chairs, directors, administrators, and members, contacting the leadership of 60 U.S. IRBs (every fourth one in the list of the top 240 institutions by NIH funding), interviewing IRB leaders from 34 (response rate=55%). IRBs describe complex direct and indirect relationships with federal agencies that affect IRBs through audits, guidance documents, and other communications, and can generate problems and challenges. Researchers often blame IRBs for frustrations, but IRBs often serve as the "local face" of federal regulations and agencies and are "stuck in the middle." These data have critical implications for policy, practice, and research.

Entities:  

Mesh:

Year:  2012        PMID: 22850143      PMCID: PMC3562716          DOI: 10.1525/jer.2012.7.3.50

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  21 in total

Review 1.  The new HIPAA (Health Insurance Portability and Accountability Act of 1996) Medical Privacy Rule: help or hindrance for clinical research?

Authors:  Jennifer Kulynych; David Korn
Journal:  Circulation       Date:  2003-08-26       Impact factor: 29.690

Review 2.  A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval.

Authors:  Sarah M Greene; Ann M Geiger
Journal:  J Clin Epidemiol       Date:  2006-03-15       Impact factor: 6.437

3.  The dysregulation of human subjects research.

Authors:  Norman Fost; Robert J Levine
Journal:  JAMA       Date:  2007-11-14       Impact factor: 56.272

4.  The use of placebo-controlled clinical trials for the approval of psychiatric drugs: part I-statistics and the case for the "greater good".

Authors:  David Feifel
Journal:  Psychiatry (Edgmont)       Date:  2009-03

5.  Reforming the regulations governing research with human subjects.

Authors:  Ezekiel J Emanuel; Jerry Menikoff
Journal:  N Engl J Med       Date:  2011-07-25       Impact factor: 91.245

6.  Views and experiences of IRBs concerning research integrity.

Authors:  Robert Klitzman
Journal:  J Law Med Ethics       Date:  2011       Impact factor: 1.718

7.  A survey of IRB process in 68 U.S. hospitals.

Authors:  Elaine Larson; Tiffany Bratts; Jack Zwanziger; Patricia Stone
Journal:  J Nurs Scholarsh       Date:  2004       Impact factor: 3.176

8.  Problematic variation in local institutional review of a multicenter genetic epidemiology study.

Authors:  Rita McWilliams; Julie Hoover-Fong; Ada Hamosh; Suzanne Beck; Terri Beaty; Garry Cutting
Journal:  JAMA       Date:  2003-07-16       Impact factor: 56.272

9.  Regulating research with human subjects--is the system broken?

Authors:  Alan R Fleischman
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

10.  How local IRBs view central IRBs in the US.

Authors:  Robert Klitzman
Journal:  BMC Med Ethics       Date:  2011-06-23       Impact factor: 2.652

View more
  4 in total

1.  The MICHR Genomic DNA BioLibrary: An Empirical Study of the Ethics of Biorepository Development.

Authors:  Blake J Roessler; Nicholas H Steneck; Lisa Connally
Journal:  J Empir Res Hum Res Ethics       Date:  2015-01-06       Impact factor: 1.742

2.  Implications of the Revised Common Rule for Human Participant Research.

Authors:  Evan G DeRenzo; Joel Moss; Eric A Singer
Journal:  Chest       Date:  2018-10-09       Impact factor: 9.410

Review 3.  Reviewing HIV-Related Research in Emerging Economies: The Role of Government Reviewing Agencies.

Authors:  Patrina Sexton; Katrina Hui; Donna Hanrahan; Mark Barnes; Jeremy Sugarman; Alex John London; Robert Klitzman
Journal:  Dev World Bioeth       Date:  2014-11-10       Impact factor: 2.294

4.  How US institutional review boards decide when researchers need to translate studies.

Authors:  Robert Klitzman
Journal:  J Med Ethics       Date:  2013-03-08       Impact factor: 2.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.